LENZ

LENZ Therapeutics is a clinical-stage biopharmaceutical company focused on developing treatments for ophthalmic conditions. The company's lead product candidate is designed to address presbyopia, the age-related loss of near vision affecting millions of people worldwide. LENZ is advancing novel pharmacological approaches to improve visual function and quality of life for patients with unmet eye care needs.